Discussion of prostate-specific antigen screening should focus on current guidelines and emphasize shared decision making, according to an article published Feb. 11 in the Urology Times.
Medical schools are beginning to change their curriculum to address ways to eliminate health disparities, according to the American Medical Association.
Value-based insurance design plans with certain features aside from solely lowering cost sharing can increase medication adherence, according to a study published in the March issue of Health Affairs.
Clearance of zolpidem (administered as a sublingual tablet) is lower in females compared to males, according to a study published in the March issue of The Journal of Clinical Pharmacology.
Although they have all participated in the development of treatment guidelines for a variety of pain conditions, 3 comprehensive pain experts openly acknowledged and discussed the practical limitations of published evidence-based recommendations during the closing session of the American Academy of Pain Medicine 2014 Annual Meeting.
Reducing high-dose opioid therapy does not worsen pain severity, functional ability, or aberrant drug-related behaviors in chronic pain patients when concurrent biopsychosocial services are offered.
Inpatients frequently receive antibiotics, and in many cases antibiotic prescribing could be improved, according to a report published in the March 4 early-release issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly.
Sometimes, chronic pain patients intentionally magnify or downplay their physical and mental symptoms during office visits. Despite that fact, little attention in the clinical setting is paid to underlying motives for positively or negatively biased self-reports.
Even if a chronic pain patient had been taking opioid medications exactly as prescribed, it would still be possible for the patient to experience negative cognitive and emotional responses to dose tapering that could amplify sensory pain and lead to opioid addiction.
In light of the fact that many physicians continue to rely on observational analysis and patient self-reporting to monitor opioid addiction or misuse, results from a scientific poster reinforced the benefits of routine urine drug testing in improving compliance with prescribed opioid medications and ultimately enhancing pain care.